US FDA completes inspection at Unit I of Eugia Pharma Specialities Ltd

The United States Food and Drug Administration (US FDA) inspected the Unit I, a Formulation manufacturing facility, of Eugia Pharma Specialities Ltd., a wholly owned subsidiary of Aurobindo Pharma Ltd, situated at Koltur Village, Shameerpet, Medchal District, Telangana, from 17th July to 26th July 2023. The inspection closed with zero observations and a classification of No Action Indicated (NAI).

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 787.55 as compared to the previous close of Rs. 785.15. The total number of shares traded during the day was 28547 in over 1168 trades.

The stock hit an intraday high of Rs. 791.40 and intraday low of 775.45. The net turnover during the day was Rs. 22421358.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 EugiaPharmaSpecialities USFDA Inspection Unit1 NoObservations